Yayın:
The effect of vasoactive intestinal peptide (VIP) and naloxone combination on survival rates in rats exposed to severe hemorrhage

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTıkız, Hakan
dc.contributor.authorTunçel, Neşe
dc.contributor.authorAkin, Mehmet Z
dc.contributor.authorGürer, Fi̇rdevs
dc.contributor.orcid0000-0002-2077-0737
dc.contributor.orcid0000-0003-2700-5840
dc.date.accessioned2025-11-13T20:50:18Z
dc.date.issued1992-01-01
dc.identifier.doihttps://doi.org/10.1016/0196-9781(92)90144-r
dc.identifier.endpage89
dc.identifier.issn0196-9781
dc.identifier.issue1
dc.identifier.openalexW1999848379
dc.identifier.startpage83
dc.identifier.urihttps://hdl.handle.net/11421/12755
dc.identifier.urihttps://doi.org/10.1016/0196-9781(92)90144-r
dc.identifier.volume13
dc.language.isoen
dc.relation.ispartofPeptides
dc.rightsrestrictedAccess
dc.subjectVasoactive intestinal peptide
dc.subjectDegranulation
dc.subject(+)-Naloxone
dc.subjectVasoactive
dc.subjectPharmacology
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectPeptide
dc.subjectEndocrinology
dc.subjectNeuropeptide
dc.subjectChemistry
dc.subjectOpioid
dc.subjectBiochemistry
dc.subject.sdg3
dc.titleThe effect of vasoactive intestinal peptide (VIP) and naloxone combination on survival rates in rats exposed to severe hemorrhage
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5015126058
local.authorid.openalexA5036918993
local.authorid.openalexA5103424769
local.authorid.openalexA5021873343

Dosyalar

Koleksiyonlar

Publications